Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yasugi

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
British Journal of Cancer|May 12, 2005
The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alphaO Wada-Hiraike, T Yano, T Nei, et al.
International Angiology : a Journal of the International Union of Angiology|April 2, 2010
Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD)H Shigematsu, T Nishibe, Y Obitsu, et al.
Cancer Letters|July 13, 2001
Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potentialC Y Xin, K Matsumoto, H Yoshikawa, et al.
British Journal of Cancer|May 4, 2013
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)N Katsumata, H Yoshikawa, H Kobayashi, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
British Journal of Cancer|May 12, 2005
The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alphaO Wada-Hiraike, T Yano, T Nei, et al.
International Angiology : a Journal of the International Union of Angiology|April 2, 2010
Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD)H Shigematsu, T Nishibe, Y Obitsu, et al.
Cancer Letters|July 13, 2001
Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potentialC Y Xin, K Matsumoto, H Yoshikawa, et al.
British Journal of Cancer|May 4, 2013
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)N Katsumata, H Yoshikawa, H Kobayashi, et al.
Pageof 11